Clinically, several studies using human cancer patients have suggested MTBP as a potential biomarker for favorable prognosis in patients with specific cancer types, including HNSCC, gastric cancer, and esophageal squamous cell carcinoma [9,11,13,14]. The gene discussed is MTBP; the disease is esophageal squamous cell carcinoma.